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OL-030 Cloning of eae genes of Escherichia coli
O157:T in pGEMT easy vector as DNA vaccine
candidate
M. Golshan1 *, M. Kargar1, A. Doosti2. 1Department of
Microbiology, Jahrom Branch, Islamic Azad University,
Jahrom, Iran, 2Biotechnology Research Center, Shahrekord
Branch, Islamic Azad University, Shahrekord, Iran
Background: Escherichia coli O157:H7 is associated with
hemorrhagic colitis, thrombotic thrombocytopenic purpura,
and hemolyticuremic syndrome in humans. In addition
to producing Shiga-like (Vero) toxin and enterohemolysin,
E. coli O157:H7 has been shown to attach to the cytoplasmic
membranes of intestinal epithelial cells, to efface their
microvilli, and to cause actin to accumulate beneath sites
of bacterial attachment. These features are shared with
several other enterohemorrhagic E. coli (EHEC) serotypes
and members of the enteropathogenic E. coli (EPEC) group.
The eae gene, which has been shown to be necessary for
attaching and effacing activity, encodes a 94- to 97-kDa
outer membrane protein (OMP) which is termed intimin.
This gene is located in a chromosomal pathogenicity island
also known as the locus of enterocyte effacement (LEE).
The gold aim of this study was cloning of eae gene of E. coli
O157:T in E. coli TOP10F strain.
Methods: The eae gene was isolated from total genome of
E. coli O157:T by PCR and eae speciﬁc PCR primers. DNA
fragment of eae gene was cloned by T/A cloning technique
in pGEMT easy vector (Invitrogen, San Diego, Calif.), and
this construct transformed into E. coli TOP10F strain.
Results: The results show that, eae was cloned in E. coli
successfully. The sequencing result conﬁrm that eae gene
was cloned is correct and BLAST outcome demonstrated the
sequences of eae is approved.
Conclusions: Therefore it seems that the DNA constract
that was produced in this study can be used for DNA vaccine
against eae of E. coli O157:T in future researchs.
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Background: KLV have been applied for its immunogenicity
in human and mice model. IMQ as adjuvant is
inducing humoral and cellular immune responses during
leishmaniasis. In this study, both KLV and IMQ were applied
in order to investigate the inhibition rate of L. major
replication and visceralization in mice.
Methods: Promastigotes of L. major were harvested
from culture, counted and used to infect Balb/c mice.
Primarily, mice were injected with KLV/IMQ, and then
they were infected by L. major intradermally with 2×106
promastigotes. Six weeks after infection, a small nodule
was appeared leading to a large lesion and visceralisation.
Effects of KLV/IMQ, physiopathological changes, lesion size,
delay of lesion formation, proliferation of amastigotes inside
MQs and detection of amastigotes in target organs were also
studied.
Result: Data analysis of body weight, rate of
hepato/splenomegaly, and survival rate indicated no
signiﬁcant differences among experimental groups. It is
concluded that both KLV and IMQ represented no cytotoxic
effects on the host, but they partly increased lesion
size; and impressed number of amastigotes inside MQs.
Application of KLV/IMQ decreased visceralization in liver and
induced liver, spleen and plasma NO. Although, application
of IMQ solely decreased visceralization in lymph nodes, but
KLV/IMQ represented no effects in concentrations of plasma
Cu/Zn and it increased liver SGOT and SGPT.
Conclusion: Unlike topical application of IMQ, injectable
IMQ presented no ameliorative affects on CL. IMQ efﬁcacy
may be associated with route, dose and number of injection,
which require more investigations.
OL-032 Expression of mRNA and protein of Fas
associated death domain protein in fulminant
hepatic failure model and the relationship of
hepatocytes apoptosis
H.Y. Ge, Z. Zhen*. Department of infection disease, The
Third Hospital of Hebei Medical University, Shijiazhuang,
China
Objective: It has been conﬁrmed that Fas associated death
domain protein (FADD) participated in many death signal
pathways induced by death receptor and has an connection
role in apoptosis signal pathway. To study the expression
of protein and mRNA of Fas associated death domain
protein (FADD) in fulminant hepatic failure (FHF) induced
by D-galactosamine (D-GalN)/lipopolysaccharide (LPS) and
the relationship of hepatocytes apoptosis.
Methods: The sensitized Wistar rat in the model group was
injected by LPS and D-GalN to induced fulminant hepatic
failure; the control group was given the same volume
physiological saline. The expression of protein and mRNA
of FADD were detected by immunohistochemistry and RT-
PCR and hepatocyte apoptosis was examined by common HE
stain and ﬂow cytometry.
Results: The liver histopathology showed apoptosis body and
inﬁltration of inﬂammatory cells after 4 h of intraperitoneal
injection of D-Gal/LPS, the hepatocyte apoptosis reached
the peak at 12 h. At 24 h hepatocyte apoptosis evidently
decreased subsequent hepatocytes necrosis occupied the
important position. The apoptotic rate reached to 27%
at 12 h. The expression of protein and mRNA of FADD
prominent were dramaticlly increased positively correlative
with hepatocyte apoptosis in D-GalN/LPS group compared
with control group.
Conclusions: The expession of FADD remarkably increased
in FHF and be closely related with hepatocyte apoptosis.
Scientiﬁcally regulation of the expression FADD may play an
important role in prevention and treatment of FHF.
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PL-005 Bioprospecting for potent anti-tuberculosis
compounds from microbial natural product
library
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Mycobacterium tuberculosis is second only to AIDS as one
of the world’s most signiﬁcant and devastating pathogens,
which has infected over one-third of world’s population, and
causes 2 million deaths annually. In the face of the catas-
trophic synergy between HIV and TB and the emergence of
MDR and XDR-MTB strains, new drugs for the chemotherapy
of tuberculosis are urgently needed. Microbial Natural
Products or their derivatives have been an important
